---
schema_version: "secwatch.filing_event.v1"
accession: "0001000228-25-000042"
form_type: "8-K"
ticker: "HSIC"
cik: "0001000228"
company_name: "HENRY SCHEIN INC"
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:20:27.814718+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Henry Schein Q2 GAAP EPS $0.70 (down 12.5% YoY); maintains FY25 guidance

## Summary
- Q2 GAAP net income $86M ($0.70 diluted EPS) vs $104M ($0.80) YoY; non-GAAP EPS $1.10 vs $1.23.
- Total sales $3.2B, up 3.3% as-reported; internal growth 1.9%; Global Medical Distribution up 6.1%.
- Adjusted EBITDA $256M vs $268M; recorded $23M restructuring costs targeting $100M+ annual run-rate savings.
- FY25 guidance maintained: non-GAAP diluted EPS $4.80-$4.94, sales growth 2%-4%, mid-single digit Adj. EBITDA growth.
- Repurchased ~3.7M shares for $259M in Q2; $432M remaining for future repurchases.

## SEC filing metadata
- accession: 0001000228-25-000042
- form_type: 8-K
- ticker: HSIC
- cik: 0001000228
- company_name: HENRY SCHEIN INC
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000228/000100022825000042/0001000228-25-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000228/000100022825000042/hsic-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001000228-25-000042
- JSON: https://secwatch.observer/filing/0001000228-25-000042.json
- Plain text: https://secwatch.observer/filing/0001000228-25-000042.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.